1. Corporate Officers - B
2. Belbel Caesar J

Insider Trading History of Belbel Caesar J

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Belbel Caesar J since 2006. The trader's CIK number is 1109753. At the time of the last reporting, Belbel Caesar J was the EVP, Chief Legal Off of Ziopharm Oncology Inc. (stock ticker symbol ZIOP). Also see all insider trading activities at Ziopharm Oncology Inc.

Note that in the past BELBEL CAESAR J also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Ziopharm Oncology Inc (ZIOP) by Belbel Caesar J

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2015	ZIOP	0	$0	153,333	$1,968,795	153,333	$352,665

Yearly summary of insider trading at Clinical Data Inc (CLDA) by Belbel Caesar J

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2007	CLDA	0	$0	10,191	$230,022	10,191	$32,712
2006	CLDA	0	$0	7,500	$173,893	7,500	$36,149

Insider trading activities at 2 companies by Belbel Caesar J:

1. Ziopharm Oncology Inc (ZIOP)

2. Clinical Data Inc (CLDA)

Table 1. Insider trading of Ziopharm Oncology Inc (ZIOP) by Belbel Caesar J

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2015-11-19	ZIOP	Option Ex	153,333	2.30	352,665
2015-11-19	ZIOP	Sale	153,333	12.84	1,968,795

Table 2. Insider trading of Clinical Data Inc (CLDA) by Belbel Caesar J

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2007-12-14	CLDA	Option Ex	2,000	3.21	6,420
2007-12-14	CLDA	Sale	2,000	22.07	44,150
2007-12-11	CLDA	Option Ex	3,950	3.21	12,679
2007-12-12	CLDA	Option Ex	4,241	3.21	13,613
2007-12-11	CLDA	Sale	3,950	22.20	87,693
2007-12-12	CLDA	Sale	4,241	23.15	98,179
2006-02-27	CLDA	Option Ex	3,094	4.82	14,913
2006-02-28	CLDA	Option Ex	1,506	4.82	7,258
2006-02-27	CLDA	Sale	3,094	23.16	71,657
2006-02-28	CLDA	Sale	1,506	22.80	34,339
2006-02-23	CLDA	Option Ex	2,000	4.82	9,640
2006-02-24	CLDA	Option Ex	900	4.82	4,338
2006-02-23	CLDA	Sale	2,900	23.41	67,897

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Belbel Caesar J (EVP, Chief Legal Off of Ziopharm Oncology Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month